PYRANTELUM Polpharma

Medicinal product

(Invented) name

PYRANTELUM Polpharma

Active substance (s)

Pirantelis

Strength

250 mg/5 ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

P02CC01, Pyrantel

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-12-18

Date of renewal

Documents

3085_PYRANTELUM Polpharma 250 mg5 ml geriamoji suspensija_PL_2025-12-18.docx

3085_PYRANTELUM Polpharma 250 mg5 ml geriamoji suspensija_PZ_2025-12-18.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

5 ml suspensijos yra:	5 ml
Pirantelis	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119542	105648	1105648	buteliukas	15 ml N1		Nereceptinis	LT/L/25/3085/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-12-18	Registruotas